Sanna Bastiano
- SEC CIK
- 0001829069
No open-market purchases or sales filed in the past year.
Current role at each company
- ACET Adicet Bio, Inc.Directoras of Aug 16, 2023
- VRTX Vertex Pharmaceuticals IncEVP, Cell & Genetic Therapiesas of May 9, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Sanna Bastiano as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
VRTX Vertex Pharmaceuticals Inc
EVP, Cell & Genetic Therapies17 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 3, 2022 (view filing) | Feb 2 | 1 day | Sanna BastianoEVP, Cell & Genetic Therapies | SSale | −1.04K | $250.98 | −$261.0K | −1.9%55.0K after | 5 lots |
| Mar 21, 2022 (view filing) | Mar 17 | 4 days | Sanna BastianoEVP, Cell & Genetic Therapies | SSale | −2.12K | $250.06 | −$530.6K | −4.2%48.4K after | |
| Apr 6, 2022 (view filing) | Apr 4-5 | 2 days | Sanna BastianoEVP, Cell & Genetic Therapies | SSale | −3.73K | $274.10 | −$1.02M | −7.9%43.3K after | 3 lots |
| Apr 8, 2022 (view filing) | Apr 7 | 1 day | Sanna BastianoEVP, Cell & Genetic Therapies | SSale | −561 | $276.18 | −$154.9K | −1.3%42.8K after | 3 lots |
| May 4, 2022 (view filing) | May 2 | 2 days | Sanna BastianoEVP, Cell & Genetic Therapies | SSale | −320 | $259.16 | −$82.9K | −0.8%41.7K after | 7 lots |
| May 6, 2022 (view filing) | May 4 | 2 days | Sanna BastianoEVP, Cell & Genetic Therapies | SSale | −36 | $275.09 | −$9.90K | −0.1%41.7K after | |
| May 18, 2022 (view filing) | May 16 | 2 days | Sanna BastianoEVP, Cell & Genetic Therapies | SSale | −45 | $252.83 | −$11.4K | −0.1%41.7K after | 5 lots |
| Oct 20, 2022 (view filing) | Oct 18 | 2 days | Sanna BastianoEVP, Cell & Genetic Therapies | SSale | −1.79K | $300.31 | −$537.9K | −4.4%39.2K after | 2 lots |
| Nov 3, 2022 (view filing) | Nov 2 | 1 day | Sanna BastianoEVP, Cell & Genetic Therapies | SSale | −320 | $312.64 | −$100.0K | −0.8%38.1K after | 7 lots |
| Feb 2, 2023 (view filing) | Jan 31 | 2 days | Sanna BastianoEVP, Cell & Genetic Therapies | SSale | −106 | $325.00 | −$34.5K | −0.3%38.0K after |